Beginner
·
Phase 2: Macroeconomics, Sectors & Portfolio Building
Day 16 – FMCG, Pharma & Defensive Sectors
13 min read
Defensive Sectors — Your Portfolio's Shock Absorbers
FMCG — Consumer Staples
People buy toothpaste, biscuits, and shampoo even in a recession. FMCG businesses have pricing power (can pass on input cost inflation), repeat purchase (not one-time), and strong distribution (HUL reaches 8 million+ retail outlets).
ITC — India's Most Controversial Blue Chip
- Cigarettes: 85% of EBIT, monopoly-like market share in India's legal cigarette market.
- Diversified into FMCG (Sunfeast, Bingo, Yippee), Hotels, Agribusiness, Paper.
- High dividend yield: 3–4%. ESG concerns keep foreign investors underweight — creating a valuation discount vs HUL.
Asian Paints — The Moat Story
- India's largest decorative paints company (55% market share).
- ROE consistently >25%, virtually zero long-term debt.
- Switching costs: contractors recommend Asian Paints; distribution reach of 70,000+ dealers creates a durable moat.
- Threat from Grasim/Birla Opus (₹10,000 crore capacity investment) compressed P/E from 60× to 40× in 2024 — worth watching.
Pharma Sector
India is the "pharmacy of the world" — supplies 40% of US generic drugs. Sun Pharma, Dr Reddy's, Cipla, and Divi's Labs are global generics players. Key risk: USFDA plant import alerts (all Indian plants are subject to inspection). Key opportunity: domestic branded generics + chronic disease drugs growing as India's middle class ages.
Key Takeaways
- Identify what makes FMCG and pharma "defensive" and when to overweight them
- Analyse ITC, HUL, and Asian Paints using FMCG-specific metrics
- Understand the Sun Pharma and Dr Reddy's model: domestic vs exports
Next lesson
Day 17 – Auto & Infra Sectors: Maruti, L&T
12 min read